Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase

Name
Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase
Accession Number
DBCAT004007
Description

Not Available

Drugs
DrugDrug Description
Cerliponase alfaAn enzyme replacement therapy used to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency.
Drugs & Drug Targets
DrugTargetType
Cerliponase alfaCation-independent mannose-6-phosphate receptortarget